ACCELRYS ANNOUNCES COMPREHENSIVE, MULTI-YEAR AGREEMENTS WITH SEVERAL INDUSTRY-LEADING PHARMACEUTICAL COMPANIES

Accelrys, Inc., including its wholly owned subsidiary, Scitegic, Inc., announced today that it entered into a number of comprehensive, multi-year agreements with some of the world's largest pharmaceutical companies during its third fiscal quarter ended December 31, 2005. These multi-year agreements, which include licenses for the Company's industry-leading computational science software and informatics platform, have durations of two to five years and represent an aggregate dollar value of $29 million over the term of the agreements.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1177233XSL_NEWSML_TO_NEWSML.xml)